Biostar announces first patient enrolled for Phase 1 study of Utidelone Capsule
UTD2 is the world's first oral epothilone microtubule inhibitor
UTD2 is the world's first oral epothilone microtubule inhibitor
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during treatment discussions that balance quality of life (QoL), efficacy, and tolerability goals across all lines of therapy
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Subscribe To Our Newsletter & Stay Updated